• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    A preliminary trial of doxorubicin in advanced breast cancer and other malignant disease.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Cole, Moya P
    Todd, Ian D
    Wilkinson, Peter M
    Affiliation
    Christie Hospital and Holt Radium Institute, Manchester
    Issue Date
    1974-02
    
    Metadata
    Show full item record
    Abstract
    Doxorubicin in a dose of 60 mg/m(2) has been used in the treatment of 23 patients with advanced malignant disease, 18 of whom had carcinoma of the breast. The drug has significant clinical activity on its own, prolonged dosage may be required to obtain a response, and there is a risk of cerebral metastases becoming manifest during treatment which is otherwise successful. Cardiac toxicity appears to be acceptably low with this dose regimen.
    Citation
    A preliminary trial of doxorubicin in advanced breast cancer and other malignant disease. 1974, 29 (2):114-6 Br. J. Cancer
    Journal
    British Journal of Cancer
    URI
    http://hdl.handle.net/10541/199549
    PubMed ID
    4598084
    PubMed Central ID
    PMC2008997
    Type
    Article
    Language
    en
    ISSN
    0007-0920
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Adriamycin-a review.
    • Authors: Carter SK
    • Issue date: 1975 Dec
    • Combination chemotherapy with adriamycin (NSC-123127) and 1-(2-chloroethyl)-3-cyclohexyl 1-nitrosourea (CCNU; NSC-79037).
    • Authors: Einhorn LH, Livingston RB, Gottlieb JA
    • Issue date: 1973 Nov-Dec
    • [Adriamycin as a single agent in various forms of advanced neoplasia of adults and children (author's transl)].
    • Authors: Bonadonna G, Beretta G, Tancini G, De Palo GM, Gasparini M, Doci R
    • Issue date: 1974 Sep-Oct
    • Difficulties designing clinical trials as exemplified by a phase 2 drug evaluation of 5(3,3-bis(2-chloroethyl)-1-triazenol)-imidazole-4-carboxamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in patients with disseminated breast cancer.
    • Authors: Ahmann DL, Bisel HF, Hahn RG
    • Issue date: 1973 Jul
    • Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue.
    • Authors: Cersosimo RJ, Hong WK
    • Issue date: 1986 Mar
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.